Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of mycophenolate mofetil in de novo lung allograft recipients
2009-012231-15Phase 3Completed
- Sponsor
- Roche
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of mycophenolate mofetil in Lung allograft rejection (LAR) and Acute lung allograft rejection (2 arms), sponsored by Roche. Primary endpoint: Primary pharmacokinetic parameters and metabolic ratios of mycophenolate mofetil. Started Sep 2009; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
Lung allograft rejection (LAR)Acute lung allograft rejection
Beyond the preview
Go deeper on 2009-012231-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012231-15.